Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

<p><strong>Background</strong></p> <p>Glucagon-like peptide-1 (GLP-1) receptor agonists differ in their structure and duration of action and have been studied in trials of varying sizes and with different patient populations, with inconsistent effects on cardiovascular...

Popoln opis

Bibliografske podrobnosti
Main Authors: Kristensen, SL, Rørth, R, Jhund, PS, Docherty, KF, Sattar, N, Preiss, D, Køber, L, Petrie, MC, McMurray, JJV
Format: Journal article
Jezik:English
Izdano: Elsevier 2019